Severe anemia on the treatment of a Lepra patient with a history of long-term steroid consumption suspect of Cushing syndrome
Article Sidebar
-
Anemia, Leprosy, Dapsone, Cushing's Syndrome
Abstract
ABSTRACT
Â
Anemia is a clinical symptom caused by the disruption of erythrocyte formation, bleeding, and premature blood hemolysis. Severe anemia can occur in patients taking dapsone for the treatment of leprosy. Long-term use of steroids is also a predisposing factor for the occurrence of hematological changes and raises the suspicion of Cushing's syndrome. Reportedly a 20-year-old woman with the main complaint of sudden shortness of breath, accompanied by a cough with phlegm. The patient has had a history of multibacillary type leprosy since a month ago. There was a history of steroid consumption for about two years and only stopped a couple of months ago. Physical examination showed the oxygen saturation was 93%, conjunctival anemia, hyperpigmented plaques, tenderness in the abdominal, meteorism, and pitting edema in the upper and lower extremities. Laboratory examination revealed hemoglobin (Hb) level 2.4 mg/dl, erythrocytes 0.8x106/ul, and albumin 3.2g/dl. Peripheral blood smear results suggest refractory anemia and myelodysplasia syndrome. After being treated for seven days, the patient was re-evaluated and controlled at the Internal Medicine outpatient clinic, Syekh Yusuf Hospital. Complex symptoms and limited investigations make it difficult to establish the exact cause. Immediate blood transfusion and management of the underlying disease causing anemia, such as discontinuation of dapsone, are the primary management of this case.
Â
Keywords               : severe anemia, leprosy, steroid, Cushing syndrome.
Correspondence       : gedepadmawijaya@yahoo.com
Full text article
References
REFERENCES
Amalia, H., Tabri, F., Vitayani, S., & Petellongi, I. (2017). Hemoglobin and ferritin serum levels on leprosy patients before multi drug therapy - world health organization (Mdt - Who) compared with healthy control group. International Journal of Sciences: Basic and Applied Research, 36(4), 74–82.
Deviana, R. (2019). Rifampisin ofloksasin Minosiklin (ROM) sebagai Terapi Alternatif Morbus Hansen. Cdk, 46, 24–27.
Dow, A., Yu, R., & Carmichael, J. (2013). Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing’s syndrome from chronic, intermittent use of intranasal betamethasone. Endocrinology, Diabetes & Metabolism Case Reports, 2013(September), 1–4. https://doi.org/10.1530/edm-13-0036
Gupta, B., Gupta, S., Chaudhary, M., Raj, A. T., Awan, K. H., & Patil, S. (2020). Hematological alterations in lepromatous leprosy: A cross-sectional observational study. Disease-a-Month, 66American(7), 100919. https://doi.org/10.1016/j.disamonth.2019.100919
Hawkins, M., Lancashire, E., Winter, D., Frobisher, C., Reulen, R., Taylor, A., … Jenney, M. (2013). The British Childhood Cancer Survivor Study: Objectives, Methods, Population Structure, Response Rates and Initial Descriptive Information. Pediatric Blood & Cancer, (February), 1388–1389. https://doi.org/10.1002/pbc
Kusumastanto, V. (2015). Sindrom Dapson pada Pasien Morbus Hansen. Cdk, 42(2), 123–126.
Manchanda, N. (2016). RODAK’S HEMATOLOGY: CLINICAL PRINCIPLES AND APPLICATIONS (5th ed.; E. M. Keohane, L. J. Smith, & W. J. M, eds.). St. Louis, Missouri 63043: Elsevier Ltd.
Muhaira, W. T., Darmi, M., & Lubis, R. D. (2018). Hemolytic anemia incident in leprosy patients receiving multi-drug therapy at Haji Adam Malik Central Hospital, Medan-Indonesia. Bali Medical Journal, 7(2), 442–446. https://doi.org/10.15562/bmj.v7i2.774
Nieman, L. K. (2015). Cushing’s syndrome: Update on signs, symptoms and biochemical screening. European Journal of Endocrinology, 173(4), M33–M38. https://doi.org/10.1530/EJE-15-0464
Oliveira, A. L. G. de, Chaves, A. T., Menezes, C. A. S., Guimarães, N. S., Bueno, L. L., Fujiwara, R. T., & Rocha, M. O. da C. (2017). Vitamin D receptor expression and hepcidin levels in the protection or severity of leprosy: a systematic review. Microbes and Infection, 19(6), 311–322. https://doi.org/10.1016/j.micinf.2017.03.001
Palimbong, F., & Kandou, R. T. (2019). Sindrom Hipersensitivitas Dapson Pada Pasien Morbus Hansen Multi- Basiler: Laporan Kasus. Jurnal Biomedik, 11(3), 150–155. https://doi.org/10.35790/jbm.11.3.2019.26331
Pante, C. C., Coelho, S. C., Carelli, L., Avancini, J., & Trindade, M. A. B. (2018). Severe adverse reactions to multidrug therapy for leprosy, registered in tertiary services between 2012 and 2017 in Brazil. Leprosy Review, 89(4), 328–334. https://doi.org/10.47276/lr.89.4.328
Supandiman, Iman, & Fadjari, H. (2014). Buku Ajar Ilmu Penyakit Dalam (6th ed.; S. Setiati, I. Alwi, A. W. Sudoyo, B. Setitohadi, & A. F. Syam, eds.). InternaPublishing.
Tamara, R., Muchtar, S. V., Amin, S., Seweng, A., Sjahril, R., & Adam, A. M. (2018). Serum Iron, Total Iron Binding Capacity and Transferrin Saturation Levels in Leprosy Patients before Multi Drug Therapy - World Health Organization (MDT-WHO) Compared with Healthy Control Group. International Journal of Medical Reviews and Case Reports, 2(0), 1. https://doi.org/10.5455/ijmrcr.leprosy-transferrin-saturation
Tang, A. S. O., Wong, Q. Y., Yeo, S. T., Ting, I. P. L., Lee, J. T. H., Fam, T. L., … Muniandy, P. (2021). Challenges in managing a lepromatous leprosy patient complicated with melioidosis infection, dapsone-induced methemoglobinemia, hemolytic anemia, and lepra reaction. American Journal of Case Reports, 22(1), 1–5. https://doi.org/10.12659/AJCR.931655
Tarigan, T. J. E. (2014). Buku Ajar Ilmu Penyakit Dalam (6th ed.; S. Setiati, I. Alwi, A. W. Sudoyo, B. Setitohadi, & A. F. Syam, eds.). InternaPublishing.
Vinod, K. V., Arun, K., & Dutta, T. K. (2013). Dapsone hypersensitivity syndrome: A rare life threatening complication of dapsone therapy. Journal of Pharmacology and Pharmacotherapeutics, 4(2), 158–160. https://doi.org/10.4103/0976-500X.110917
Wiryo, I. T. (2018). Kusta Tipe Borderline Lepromatosa Dengan Eritema Nodosum Leprosum Berat , Anemia Dan Cacat Kusta Tingkat 2. Jurnal, 53(9), 1689–1699.
Yacoub, M. F., Ferwiz, H. F., & Said, F. (2020). Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases. Anemia, 2020. https://doi.org/10.1155/2020/3041738
Yiannikourides, A., & Latunde-Dada, G. (2019). A Short Review of Iron Metabolism and Pathophysiology of Iron Disorders. Medicines, 6(3), 85. https://doi.org/10.3390/medicines6030085
Authors
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.